Screening and Management of Intracranial Aneurysms in Adults with ADPKD

Indications for Screening

• Adults with ADPKD who have a personal history of subarachnoid hemorrhage (SAH) should be screened for intracranial aneurysms regardless of other factors – strong recommendation from KDIGO 2025 guidelines. 1
• Adults with ADPKD who have a first‑degree relative with an intracranial aneurysm, SAH, or unexplained sudden death should be screened – KDIGO 2025 recommendation; the prevalence of aneurysms rises from ~10‑11 % in those without a family history to 16‑23 % with a positive family history (evidence from Stroke 2015 and JACR 2021). [1][2]3
• Screening should be considered in the pre‑transplant setting, before major elective surgery, and before conception in women who otherwise meet screening criteria – KDIGO 2025 guidance. 1
• Children with ADPKD are not recommended for routine screening because aneurysm rupture is exceedingly rare in childhood – consensus from Nature Reviews Nephrology 2019. 4
• Patients with limited life expectancy or who would not be candidates for aneurysm treatment should not be screened – KDIGO 2025 recommendation. 1

Preferred Imaging Modality

• Time‑of‑flight magnetic resonance angiography (TOF‑MRA) without gadolinium is the first‑line screening test – KDIGO 2025 guideline (strong recommendation). 1
• TOF‑MRA demonstrates a sensitivity of ~86 % and specificity of ~84 % for detecting intracranial aneurysms – data from the American College of Radiology (JACR 2021). 3
• TOF‑MRA is non‑invasive, involves no ionizing radiation, and requires no contrast agent – American College of Radiology evidence. 3
• High‑resolution CT angiography (CTA) is an acceptable alternative when MRA is contraindicated or unavailable – KDIGO 2025 guidance. 1
• CTA provides >90 % sensitivity for aneurysm detection, but its performance declines markedly for aneurysms <3 mm or those adjacent to bone – American College of Radiology data. 3
• Catheter angiography is not recommended for screening because procedural risks outweigh any incremental diagnostic benefit – American College of Radiology recommendation. 3

Rescreening Strategy

• In high‑risk patients with an initial negative TOF‑MRA, individualized rescreening every 5–10 years is advised, taking into account age, remaining life expectancy, and evolving risk factors – KDIGO 2025 recommendation. 1
• If an aneurysm is identified, surveillance and treatment plans should be formulated by a multidisciplinary team at a high‑volume center – KDIGO 2025 guidance. 1

Management of Detected Aneurysms

• All detected aneurysms should be evaluated at a high‑volume center with a multidisciplinary team (neurosurgery, interventional neuroradiology, etc.) – KDIGO 2025 recommendation. 1
• Management options include:
  
  • Conservative surveillance for small, low‑risk lesions (evidence from Stroke 2015). 2
  • Microsurgical repair when anatomically appropriate (KDIGO 2025). 1
  • Endovascular repair as an alternative minimally invasive option (KDIGO 2025). 1

Mandatory Risk‑Factor Modification

• Smoking cessation is essential; smoking is the strongest modifiable risk factor for aneurysm formation and rupture – KDIGO 2025 strong recommendation. 1
• Behavioral counseling and pharmacologic therapies should be offered to support cessation – KDIGO 2025. 1
• Aggressive blood‑pressure control is required; uncontrolled hypertension markedly increases aneurysm formation and rupture risk – KDIGO 2025 strong recommendation. 1

Patient Education & Emergency Recognition

• Patients should be educated that a sudden “thunderclap” headache (maximal intensity within seconds to one minute) is the hallmark sign of aneurysmal rupture and warrants immediate emergency evaluation – KDIGO 2025 recommendation. 1
• All individuals with ADPKD should be informed of their elevated aneurysm risk even if they are not screened – KDIGO 2025. 1
• Counseling should address potential psychosocial and insurance implications of a positive screening result – KDIGO 2025 and Stroke 2015 evidence. [1][2]

Common Pitfalls to Avoid

• Do not implement universal screening; selective screening based on personal or family history is the guideline‑endorsed approach – KDIGO 2025 (strong recommendation). [1][2]
• Do not use catheter angiography for routine screening – American College of Radiology recommendation. 3
• Do not assume that aneurysms in ADPKD patients have a higher rupture risk; studies show rupture rates comparable to the general population for similarly sized aneurysms – evidence from Stroke 2015. 5
• Do not neglect smoking cessation and blood‑pressure control even in patients who are not screened – KDIGO 2025 strong recommendation. 1

Cerebral Aneurysm Risk Assessment in Patients with Polycystic Kidney and Liver Disease

Introduction to Risk Factors

• Patients with autosomal dominant polycystic kidney disease (ADPKD) have an increased prevalence of intracranial aneurysms, ranging from 6% to 11.5% in those without a family history of aneurysm, according to the American College of Radiology 6, 7
• The risk increases to 16% to 23% in patients with ADPKD who also have a family history of intracranial aneurysm or hemorrhagic stroke, as recommended by the Kidney International guidelines 6, 8

Indications for Screening

• Patients with ADPKD and a personal history of subarachnoid hemorrhage should undergo screening, as suggested by the Kidney International guidelines 8, 9
• Patients with ADPKD and a positive family history of intracranial aneurysm, subarachnoid hemorrhage, or sudden unexplained death should also be screened, according to the Kidney International guidelines 8, 9

Screening Methods

• Magnetic resonance angiography (MRA) without contrast using the time-of-flight technique is the preferred screening method, as recommended by the Journal of the American College of Radiology 8, 9, 7
• High-resolution computed tomography angiography (CTA) may be an alternative, as suggested by the Journal of the American College of Radiology 8, 9, 7

Management of Identified Aneurysms

• When one or more aneurysms are identified, treatment options (conservative management, microvascular repair, or endovascular treatment) should be evaluated in a multidisciplinary setting, as recommended by the Kidney International guidelines 8, 9

Modifiable Risk Factors

• Smoking is a strong modifiable risk factor for the development and rupture of intracranial aneurysms, as suggested by the Kidney International guidelines 8, 9
• Uncontrolled hypertension is also an important modifiable risk factor, according to the Kidney International guidelines 8, 9

Patient Education

• Patients should be educated to recognize symptoms of aneurysm rupture, such as thunderclap headache (sudden onset of severe headache that reaches maximum intensity within seconds to minutes), as recommended by the Kidney International guidelines 8, 9
• Implications of detecting intracranial vascular abnormalities (such as eligibility for life insurance) and anxiety should be considered and discussed with the patient, as suggested by the Kidney International guidelines 8, 9

Screening for Cerebral Aneurysms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Recommended First‑Line Imaging Modality

• The American College of Radiology designates non‑contrast time‑of‑flight magnetic resonance angiography (MRA) of the head as the “ideal screening study of choice” for detecting intracranial aneurysms in ADPKD patients, assigning it an appropriateness rating of 8/9. 10
• Non‑contrast MRA is non‑invasive, involves no ionizing radiation, and requires no contrast agents, making it safe for repeated lifetime screening. 11
• Diagnostic performance of non‑contrast MRA for aneurysm detection is ≈95 % sensitivity and ≈89 % specificity. 11
• Because many ADPKD patients have renal impairment, non‑contrast MRA avoids nephrotoxic iodinated contrast, preserving kidney function. 10

When Alternative Imaging Is Needed

• Computed tomography angiography (CTA) with IV contrast is an acceptable alternative when MRA is contraindicated or unavailable; it also receives an appropriateness rating of 8/9 from the American College of Radiology. [10][11]
• CTA provides >90 % sensitivity and specificity for aneurysm detection. 11
• CTA is superior for follow‑up of previously clipped aneurysms. 10
• CTA’s sensitivity declines for aneurysms <3 mm or those located adjacent to bone. 11

Technical Considerations for Optimal MRA Detection

• 3‑Tesla (3T) MRI scanners yield higher diagnostic accuracy than 1.5‑Tesla systems, especially for aneurysms <5 mm in size. 11
• Vessel loops and infundibular vessel origins can mimic aneurysms on MRA, potentially generating false‑positive findings. 11

Situations Requiring Screening (High‑Risk Indications)

• A first‑degree relative with an intracranial aneurysm, subarachnoid hemorrhage, or unexplained sudden death raises aneurysm prevalence in ADPKD patients from 10‑11 % to 16‑23 %. 11

Imaging Modalities Not Recommended for Routine Screening

• Standard MRI of the head without contrast (using only T1/T2/FLAIR sequences) receives a low appropriateness rating of 5‑6/9 and provides inadequate vascular detail for aneurysm screening. 10
• Catheter (digital subtraction) angiography is not recommended for routine screening in asymptomatic ADPKD patients because its procedural morbidity is ≈0.2 %, and it carries an appropriateness rating of 2/9. [11][10]
• Non‑contrast CT of the head is also inappropriate for aneurysm screening, with an appropriateness rating of 3‑4/9. [10][11]